A carregar...
Gene therapy and genome editing for primary immunodeficiency diseases
In past two decades the gene therapy using genetic modified autologous hematopoietic stem cells (HSCs) transduced with the viral vector has become a promising alternative option for treating primary immunodeficiency diseases (PIDs). Despite of some pitfalls at early stage clinical trials, the field...
Na minha lista:
| Publicado no: | Genes Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Chongqing Medical University
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7063425/ https://ncbi.nlm.nih.gov/pubmed/32181274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gendis.2019.07.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|